Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides
Inventors
May, Andrew Paul • Donohoue, Paul Daniel
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present disclosure provides DNA-guided CRISPR systems; polynucleotides comprising DNA, RNA and mixtures thereof for use with CRISPR systems; and methods of use involving such polynucleotides and DNA-guided CRISPR systems.
Core Innovation
The invention is a method for modulating transcription of at least one gene within a target deoxyribonucleic acid (DNA) molecule by contacting a target DNA molecule comprising a target sequence in vitro or in an isolated cell with a single polynucleotide and a Cpf1 protein. The single polynucleotide includes a targeting region comprising a mixture of DNA and ribonucleic acid (RNA) and an activating region comprising a mixture of DNA and RNA, with the activating region adjacent to the targeting region.
The targeting region hybridizes with the target sequence, and the activating region comprises a stem loop structure. The method further requires a Cpf1 protein that has no nuclease activity, where the Cpf1 protein is capable of binding with the activating region of the single polynucleotide.
The disclosure also emphasizes hybrid DNA/RNA guide-polynucleotide designs in which an activating region containing secondary structures interacts with Cpf1 or Cas9 proteins. It motivates the use of DNA-guided Class 2 CRISPR systems by addressing RNA-guided CRISPR issues and by improving specificity, including reducing off-target and increasing on-target specificity.
Claims Coverage
The independent claim set provided includes 1 independent claim. Across the claim family shown, the inventive features include a DNA/RNA hybrid single polynucleotide with adjacent targeting and stem-loop activating regions plus nuclease-inactive Cpf1 binding to the activating region, for modulating transcription in vitro or in an isolated cell.
Nuclease-inactive Cpf1 for transcription modulation with DNA/RNA single polynucleotide
A method of modulating transcription of at least one gene within a target DNA molecule by contacting a target DNA molecule comprising a target sequence in vitro or in an isolated cell with a single polynucleotide having an adjacent targeting region and activating region, and a Cpf1 protein that has no nuclease activity but is capable of binding the activating region.
Hybrid DNA/RNA targeting region that hybridizes to the target sequence
The single polynucleotide includes a targeting region comprising a mixture of DNA and RNA configured to hybridize with the target sequence.
Stem-loop DNA/RNA activating region adjacent to the targeting region
The single polynucleotide includes an activating region comprising a mixture of DNA and RNA, adjacent to the targeting region, where the activating region comprises a stem loop structure.
Cpf1 binds activating region despite no nuclease activity
The Cpf1 protein has no nuclease activity and is capable of binding with the activating region of the single polynucleotide.
The claim coverage centers on transcription modulation using a single hybrid DNA/RNA polynucleotide with a stem-loop activating region adjacent to a target-hybridizing region, coupled with a nuclease-inactive Cpf1 protein that binds the activating region.
Stated Advantages
Reducing off-target and increasing on-target specificity.
Improved specificity relative to RNA-guided CRISPR, as motivated in the disclosure.
Documented Applications
Cleavage or transcription modulation within a target DNA molecule.
Donor-mediated genome editing.
Plant genome editing, including maize embryos.
Type V Cpf1 guide element designs associated with Cpf1 cutting concepts.
Interested in licensing this patent?